• 1. Fe3O4/FeS2 heterostructures enable efficient oxygen evolution reaction?
  Xingqun Zheng,Lele Song,Xin Feng,Li Li,Zidong Wei J. Mater. Chem. A, 2020,8, 14145-14151
• 2. Enantiomeric helical TiO2 nanofibers modulate different peptide assemblies and subsequent cellular behaviors?
  Xu Jie,Deng Xu,Weili Wei RSC Adv., 2019,9, 29149-29153
• 3. Excited state dynamics of symmetric and asymmetric Cr3(dpa)4Cl2 measured using femtosecond transient absorption spectroscopy?
  Chao-Han Cheng,Wen-Zhen Wang,Shie-Ming Peng,I-Chia Chen Phys. Chem. Chem. Phys., 2017,19, 25471-25477
• 4. Distribution and ecological risk assessment of typical antibiotics in the surface waters of seven major rivers, China?
  Environ. Sci.: Processes Impacts, 2021,23, 1088-1100
• 5. Distribution pattern and allocation of defects in hydrogenated ZnO thin films?
  Vitaly Gurylev,Chung-Yi Su,Tsong-Pyng Perng Phys. Chem. Chem. Phys., 2016,18, 16033-16038

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Biphenyls and derivatives

Professional Introduction to 4-Fluoro-2-(2-trifluoromethylphenyl)benzoic Acid (CAS No. 1261871-99-1)

4-Fluoro-2-(2-trifluoromethylphenyl)benzoic acid, with the chemical identifier CAS No. 1261871-99-1, is a significant compound in the realm of pharmaceutical and chemical research. This compound belongs to the class of benzoic acid derivatives, characterized by its unique structural features that include a fluoro substituent at the fourth position and a trifluoromethylphenyl group at the second position. These structural attributes contribute to its distinctive chemical properties, making it a valuable intermediate in the synthesis of various pharmacologically active molecules.

The presence of both fluoro and trifluoromethyl groups in the molecular structure of 4-fluoro-2-(2-trifluoromethylphenyl)benzoic acid imparts significant electronic and steric effects. The fluoro group is known for its ability to modulate metabolic stability and binding affinity, while the trifluoromethyl group enhances lipophilicity and metabolic resistance. These properties make the compound particularly interesting for drug discovery and development, as they can influence both the pharmacokinetic and pharmacodynamic profiles of potential therapeutic agents.

In recent years, there has been growing interest in benzoic acid derivatives due to their diverse biological activities. Studies have demonstrated that compounds containing these structural motifs exhibit a range of pharmacological effects, including anti-inflammatory, antimicrobial, and anticancer properties. The specific combination of substituents in 4-fluoro-2-(2-trifluoromethylphenyl)benzoic acid positions it as a promising candidate for further investigation in these areas.

One of the most compelling aspects of 4-fluoro-2-(2-trifluoromethylphenyl)benzoic acid is its potential application in the development of novel therapeutic agents. Researchers have been exploring its utility as a precursor in the synthesis of small-molecule inhibitors targeting various disease pathways. For instance, studies have indicated that derivatives of this compound may interact with enzymes involved in cancer cell proliferation and survival, offering a potential therapeutic strategy for oncological applications.

The synthetic pathways for 4-fluoro-2-(2-trifluoromethylphenyl)benzoic acid have also been subjects of considerable interest. The synthesis typically involves multi-step organic transformations, including fluorination and trifluoromethylation reactions, which are critical for introducing the characteristic functional groups into the molecule. Advances in synthetic methodologies have enabled more efficient and scalable production processes, making it feasible to conduct large-scale studies and clinical trials.

The pharmacological evaluation of 4-fluoro-2-(2-trifluoromethylphenyl)benzoic acid has revealed several intriguing findings. Preclinical studies have shown that this compound exhibits moderate binding affinity to certain biological targets, suggesting its potential as a lead compound for further optimization. Additionally, its structural features have been found to enhance drug-like properties such as solubility and bioavailability, which are essential for successful drug development.

In conclusion, 4-fluoro-2-(2-trifluoromethylphenyl)benzoic acid (CAS No. 1261871-99-1) represents a fascinating compound with significant potential in pharmaceutical research. Its unique structural composition and demonstrated biological activities make it a valuable asset in the quest for novel therapeutic agents. As research continues to uncover new applications and synthetic strategies for this compound, its importance in drug discovery is likely to grow even further.

• 1261741-41-6(5-Fluoro-3-(2-trifluoromethylphenyl)benzoic acid)
• 1261950-34-8(3-(3,5-Difluorophenyl)-5-trifluoromethylbenzoic acid)
• 1261772-10-4(5-Fluoro-3-(3-trifluoromethylphenyl)benzoic acid)
• 926221-15-0(5-Fluoro-3'-(trifluoromethyl)[1,1'-biphenyl]-2-carboxylic acid)
• 926200-33-1(5-Fluoro-2-3-(Trifluoromethyl)PhenylBenzoic Acid)
• 654-99-9(5-Fluoro-2-(trifluoromethyl)benzoic acid)
• 1261824-93-4(5-Fluoro-3-(4-trifluoromethylphenyl)benzoic acid)
• 1179762-71-0(4-fluoro-2-[4-(trifluoromethyl)phenyl]benzoic acid)
• 1261750-21-3(6-Fluoro-2-(3-trifluoromethylphenyl)benzoic acid)
• 141179-72-8(4-Fluoro-2-(trifluoromethyl)benzoic acid)